Why this IndyCar driver is outpacing diabetes

May 25, 2017 by David Ferguson , Sarina Gleason, Michigan State University
MIchigan State University kinesiologist David Ferguson works with professional IndyCar driver Charlie Kimball to manage his diabetes and help him become a more powertful athlete while improving his performance on the racetrack. Credit: Derrick Turner, Michigan State University

New Michigan State University research is the first to help a professional race car driver with diabetes improve his performance during competition, helping him capture two top-5 finishes at the Indianapolis 500.

The study focused on 31-year-old race car driver Charlie Kimball, but the implications could extend well beyond racing and help other elite-level athletes with the disease compete.

"Our research focused on tracking all the health variables of Charlie related to his diabetes in order to help him become a more powerful athlete," said David Ferguson, lead author of the study who has worked with Kimball for the past six years.

"Even though our study was tailored for racing, the idea of optimal could really extend to any athlete with diabetes and help lay the foundation for all diabetics to engage in competitive sports based on our data."

Kimball, one of two IndyCar drivers with Type 1 diabetes and one of four in elite-level racing overall, has to consider a lot more safety precautions than most other drivers when he gets behind the wheel.

"Monitoring sugar is one of the most obvious precautions someone like Charlie needs to consistently keep track of before getting on the racetrack," Ferguson said. "If his blood sugar is too low, it may take him too long to make the right decision. If his is too high, his reaction time may be fine, but the likelihood of him making the wrong choice increases."

Michigan State University research is the first to help a professional race car driver with diabetes improve his performance during competition, helping him capture two top-5 finishes at the Indy 500. The study, led by kinesiologist David Ferguson, focuses on 31-year-old race car driver Charlie Kimball, but the implications could extend well beyond racing and help other elite-level athletes with the disease compete. Credit: Michigan State University

Ferguson's research-based regimen has Kimball's physical composition and health fluctuations down to a science, indicating optimum glucose levels for the professional driver at race time, as well as knowing how his body will respond to extreme forces and movements that occur while in the car.

In addition to identifying , the study monitored other physiological factors including body composition, strength, cardiovascular fitness and how much G-force his body could handle.

"Drivers are subjected to an increased gravitational force while racing," Ferguson said. "Blood can pool in the legs on a high G-force track and impair performance."

By helping Kimball manage his health and monitor many of the environmental factors he faces while racing, Ferguson said the research has put Charlie in the top 10 percent of physical fitness of the athletes he has tested. It's also given him the ability to compete equally with others.

David Ferguson, an MSU kinesiologist, has worked with professional IndyCar driver Charlie Kimball for the past six years to help him manage his diabetes and improve his performance on the racetrack. Credit: Derrick Turner, Michigan State University

"Technically, since Charlie doesn't have a functioning pancreas, all the other have had an advantage over him," Ferguson said. "We simply put him on a level playing field."

Ferguson is presenting the study at the annual meeting of the American College of Sports Medicine on May 31.

Explore further: Why the fast and the furious need H2O

Related Stories

Why the fast and the furious need H2O

June 11, 2015
The demands of a big race can make some motorsports athletes go to water – and that's where The University of Queensland comes in.

Artificial pancreas improves blood sugar control in young kids

April 3, 2017
An artificial pancreas, which delivers insulin in an automated way to individuals with type 1 diabetes, appears to be safe and effective for use in children ages 5 to 8 years, a new study finds. Results will be presented ...

What is pre-diabetes?

December 3, 2015
According to the American Diabetes Association, an estimated 86 million Americans age 20 and older have pre-diabetes. "If you've been diagnosed with pre-diabetes, it means your blood sugar levels are not high enough to be ...

Experts recommend continuous glucose monitors for adults with type 1 diabetes

September 26, 2016
The Endocrine Society today issued a Clinical Practice Guideline recommending continuous glucose monitors (CGMs) as the gold standard of care for adults with Type 1 diabetes.

FDA approves 'artificial pancreas' to manage diabetes (Update)

September 28, 2016
Federal regulators have approved a first-of-a-kind "artificial pancreas," a device that can help some diabetes patients manage their disease by constantly monitoring their blood sugar and delivering insulin as needed.

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.